Skip navigation

ASS

ASS Dexcel Protect 100 mg magensaftres.Tabletten

Product from
Preussen
100 pcs
€3.99 €0.04 /pc

Zu Risiken und Nebenwirkungen lesen Sie die Packungsbeilage und fragen Sie Ihre Ärztin, Ihren Arzt oder in Ihrer Apotheke.

Similar products

More from this brand


You're reading an Auto-translation.

Important notes (mandatory information)

ASS Dexcel Protect 100 mg, enteric-coated tablets. Active ingredient: acetylsalicylic acid. Areas of application: for unstable angina pectoris (heart pain due to circulatory disorders in the coronary arteries) - as part of standard therapy, for acute heart attack - as part of standard therapy, for the prevention of another heart attack after the first heart attack (for reinfarction prophylaxis), after operations or other interventions on arterial blood vessels (after arterial vascular surgical or interventional interventions, e.g. after aortocoronary vein bypass [ACVB], with percutaneous transluminal coronary angioplasty [PTCA]) and for the prevention of temporary insufficient blood flow to the brain (TIA: transient ischemic attacks) and cerebral infarctions, after precursor stages (e.g. temporary paralysis in the face or arm muscles or temporary loss of vision) have occurred.

For risks and side effects, read the package leaflet and ask your doctor or pharmacist.


This information was last revised in November 2014.

Source: Information from the package leaflet
Status: 06/2018
Active ingredient: acetylsalicylic acid. Areas of application: for unstable angina pectoris (heart pain due to circulatory disorders in the coronary arteries) - as part of standard therapy, for acute heart attack - as part of standard therapy, for the prevention of another heart attack after the first heart attack (for reinfarction prophylaxis), after operations or other interventions on arterial blood vessels (after arterial vascular surgical or interventional interventions, e.g. after aortocoronary vein bypass [ACVB], with percutaneous transluminal coronary angioplasty [PTCA]) and for the prevention of temporary insufficient blood flow to the brain (TIA: transient ischemic attacks) and cerebral infarctions, after precursor stages (e.g. temporary paralysis in the face or arm muscles or temporary loss of vision) have occurred.


Wirkstoff: Acetylsalicylsäure